Common QTc Formula Can Led to Wrong Chemo Decisions

A formula commonly used to calculate QT interval prolongation overestimates the risk and may be leading to inappropriate chemotherapy decisions.

Related Keywords

Boston ,Massachusetts ,United States ,New Hampshire ,Framingham ,Lebanon ,Benjamin Starobin ,Joshuaf Zeidner ,Daniel Richardson ,Kevin Kwaku ,Bristol Myers Squibb ,Genentech ,University Of North Carolina At Chapel Hill ,Hitchcock Medical Center ,National Institutes Of Health ,Boston Scientific ,University Of North Carolina Cancer Hospital ,North Carolina ,Chapel Hill ,Dartmouth Hitchcock Medical Center ,North Carolina Cancer Hospital ,National Institutes ,Chemotherapy ,Cancer ,Alignant Neoplasia ,Arcinoma ,Arrhythmia ,Becg ,Electrocardiogram ,Ekg ,Electrophysiology ,Holter ,Ecg Monitoring ,Electrocardiogram Monitoring ,Holter Monitoring ,Antineoplastic Drug ,Nti Cancer Agents ,Evacizumab ,Rlotinib ,Efitinib ,Matinib ,Ituximab ,U11248 ,Unitinib ,Rastuzumab ,Physician Assistants ,